The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey U. Över, D. Gür, S. Ünal,

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

L. Boyanova Clinical Microbiology and Infection

High prevalence of azithromycin resistance to Treponema pallidum in geographically different areas in China X.-S. Chen, Y.-P. Yin, W.-H. Wei, H.-C. Wang,

In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria Matthew W. Ruble, Deborah H. Gilbert, Stephen.

Gut bacterial microbiota and obesity

I.J. Schalk Clinical Microbiology and Infection

Approach to diagnosis of infective endocarditis

Time-trends for Gram-negative and multidrug-resistant Gram-positive bacteria associated with nosocomial infections in German intensive care units between.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram- positive bacteria M.J. Rybak Clinical Microbiology and Infection

Herpes zoster in non-hospitalized children

The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey U. Över, D. Gür, S. Ünal,

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus A. Carricajo,

Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.

Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries J.A. Otter, N.T. Mutters, E. Tacconelli, A.

P. Nordmann, L. Poirel Clinical Microbiology and Infection

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Rodríguez-Gómez, O. Cuevas, J. Anguita, P. Muñoz

Surveillance of Legionnaires’ disease in Austria

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

Molecular mechanism of gentamicin resistance in Bartonella henselae

Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models D.L. Monnet, J.-M. López-Lozano,

New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

A. Fajardo, J.F. Linares, J.L. Martínez

Integrons and gene cassettes in clinical isolates of co-trimoxazole-resistant Gram- negative bacteria M. Grape, A. Farra, G. Kronvall, L. Sundström Clinical.

Laboratory diagnosis and biosafety issues of biological warfare agents

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Contemporary resistance trends and mechanisms for the old antibiotics colistin, temocillin, fosfomycin, mecillinam and nitrofurantoin C.G. Giske Clinical.

C. S. Higgins, S. M. Murtough, E. Williamson, S. J. Hiom, D. J

Metagenomics and probiotics

Advisory group on Home-based and Outpatient Care (AdHOC): an international consensus statement on non-inpatient parenteral therapy D. Nathwani, J.-J.

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

Recent developments in staphylococcal scalded skin syndrome

S8 – S47 and O50 – O440 Clinical Microbiology and Infection

A. Bryskier Clinical Microbiology and Infection

R. Colebunders, P. Michielsen Clinical Microbiology and Infection

Campylobacter fetus pericarditis in a patient with β-thalassemia: case report and review of the literature S.S. Kanj, G.F. Araj, A. Taher, L.B. Reller

Community-acquired pneumonia: epidemiologic and clinical consideration

Abstracts cont. Clinical Microbiology and Infection

Training in infectious diseases and tropical medicine in Britain

Clinical infection services—the Leiden experience

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

W. Eugene Sanders, Christine C. Sanders

Overview of cefixime use in community-acquired infections

A. Norberg, C.E. Nord, B. Evengård Clinical Microbiology and Infection

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

Clinical microbiological case: thermointolerant microorganism growth in blood cultures and catheter tip M. Blasco-Navalpotro, M. Jordán, J.J. Camarena,

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

Typing of Clostridium difficile

New patterns of HIV-1 resistance during HAART

Joshua P. Metlay, Daniel E. Singer Clinical Microbiology and Infection

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey U. Över, D. Gür, S. Ünal, G.H. Miller Clinical Microbiology and Infection Volume 7, Issue 9, Pages 470-478 (September 2001) DOI: 10.1046/j.1198-743x.2001.00284.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 The sites of acetylation (AAC), adenylation (ANT) and phosphorylation (APH) of aminoglycoside molecules by modification enzymes and the genes encoding these enzymes. Inactivation sites of the clinically useful aminoglycosides (gentamicin (G), tobramycin (T), netilmicin (N), amikacin (A), isepamicin (I) or kanamycin (K)) are indicated for each enzyme. Clinical Microbiology and Infection 2001 7, 470-478DOI: (10.1046/j.1198-743x.2001.00284.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 The prevalence of aminoglycoside resistance mechanisms in Gram-negative bacteria. Clinical Microbiology and Infection 2001 7, 470-478DOI: (10.1046/j.1198-743x.2001.00284.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions